IRBM's drug discovery research is featured on the cover of this issue's ACS Publications' Medicinal Chemistry Letters - IRBM
Featured Letter in ACS Medicinal Chemistry Letters – NITSCHE LAB
![Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/acsmedchemlett.6b00242/asset/images/acsmedchemlett.6b00242.social.jpeg_v03 "Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents | ACS Medicinal Chemistry Letters")
Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents | ACS Medicinal Chemistry Letters
ACS Med Chem Lett on Twitter: "Our new issue is out with cover art depicting the mechanism of action of vorasidenib (AG-881), a dual inhibitor of mutant IDH1 and 2 for the
ACS Medicinal Chemistry Letters | Vol 11, No 11
ACS Medicinal Chemistry Letters: Volume 11, Issue 5
ACS Medicinal Chemistry Letters Referencing Guide · ACS Medicinal Chemistry Letters citation (updated May 21 2023) · Citationsy
Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist | ACS Medicinal Chemistry Letters
A CIQUS paper among the most read articles in ACS Medicinal Chemistry Letters last month | CiQUS -USC - University of Santiago de Compostela
In press on ACS Med. Chem. Lett.! - SARA (Fortuna) Research Team
ACS Medicinal Chemistry Letters | Vol 11, No 10
ACS Medicinal Chemistry Letters | Vol 11, No 10
American Chemical Society, Puget Sound Section - Women's History Month. ACS Medicinal Chemistry Letters celebrates women in medicinal chemistry with a Special Issue. https://pubs.acs.org/toc/amclct/11/3 (The cover shows some of the contributors to
Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors | ACS Medicinal Chemistry Letters
Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C | ACS Medicinal Chemistry Letters
ACS Med. Chem. Lett. | PROTAC targeted FLT3 - ITD proteins: new therapy of acute myeloid leukemia
Publications – Santos Lab
ACS Med Chem Lett Paper Accepted!
Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation | ACS Medicinal Chemistry Letters
ACS MedChem Lett | Cambridge MedChem Consulting
ACS Med Chem Lett (@ACSMedChemLett) / Twitter
PDF) ACS Medicinal Chemistry Letters - Tyrosinase inhibitors - Romain Haudecoeur
A memo about New approach of Drug discovery from ACS medchem letters #memo #journal #RIBOTAC – Is life worth living?
Our collaborative work with Scott Lokey's Lab at UCSC on PROTAC structure-permeability relationships is now published in ACS Med Chem Lett | Ciulli Laboratory
ACS Med Chem 2011 (2) 919-923
ACS Med Chem Lett (@ACSMedChemLett) / Twitter
